GYRE THERAPEUTICS, INC. 8-K

What Happened
Gyre Therapeutics, Inc. filed a Current Report on Form 8-K on May 14, 2026 (Item 7.01) to disclose that it will present an attached presentation at a scientific conference in Shanghai, China on May 15, 2026. The presentation is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference. The filing was made as a Regulation FD disclosure.

Key Details

• Filing date: May 14, 2026 (Form 8-K, Item 7.01).
• Presentation date and location: May 15, 2026 — scientific conference in Shanghai, China.
• Exhibit furnished: Presentation dated May 2026 (Exhibit 99.1) is attached to the 8-K.
• Disclosure type: Furnished under Regulation FD (ensures public availability of the presentation).

Why It Matters
This filing gives investors public access to the company’s conference presentation materials (Exhibit 99.1). Retail investors should review the attached presentation for any scientific, clinical or business updates that could be material to Gyre’s outlook. The 8-K does not report financial results or executive changes; it simply furnishes the presentation under Reg FD.